These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 36339684)
1. An Unsupervised Deep Learning-Based Model Using Multiomics Data to Predict Prognosis of Patients with Stomach Adenocarcinoma. Chen S; Zang Y; Xu B; Lu B; Ma R; Miao P; Chen B Comput Math Methods Med; 2022; 2022():5844846. PubMed ID: 36339684 [TBL] [Abstract][Full Text] [Related]
2. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets. Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873 [TBL] [Abstract][Full Text] [Related]
3. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma. Han C; Zhang C; Wang H; Li K; Zhao L BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056 [TBL] [Abstract][Full Text] [Related]
4. Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer. Li X; Pasche B; Zhang W; Chen K JAMA Oncol; 2018 Dec; 4(12):1691-1698. PubMed ID: 30098163 [TBL] [Abstract][Full Text] [Related]
5. Survival prediction in patients with colon adenocarcinoma via multi-omics data integration using a deep learning algorithm. Lv J; Wang J; Shang X; Liu F; Guo S Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33258470 [TBL] [Abstract][Full Text] [Related]
6. Based on the Cancer Genome Atlas Database Development of a prognostic model of RNA binding protein in stomach adenocarcinoma. Abbas Raza SH; Zhong R; Xing S; Yu X; Chengcheng L; Zan L; Schreurs NM; Pant SD; Lei H Comput Biol Med; 2023 Sep; 164():107307. PubMed ID: 37544249 [TBL] [Abstract][Full Text] [Related]
7. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma. Wu P; Zheng Y; Wang Y; Wang Y; Liang N J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329 [TBL] [Abstract][Full Text] [Related]
8. Identification of a three-gene expression signature and construction of a prognostic nomogram predicting overall survival in lung adenocarcinoma based on TCGA and GEO databases. Zhou Y; Gao S; Yang R; Du C; Wang Y; Wu Y Transl Lung Cancer Res; 2022 Jul; 11(7):1479-1496. PubMed ID: 35958325 [TBL] [Abstract][Full Text] [Related]
9. Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction. Hu X; Wu L; Liu B; Chen K Front Immunol; 2021; 12():651056. PubMed ID: 34122409 [TBL] [Abstract][Full Text] [Related]
10. A novel microRNA signature predicts survival in stomach adenocarcinoma. Ding B; Gao X; Li H; Liu L; Hao X Oncotarget; 2017 Apr; 8(17):28144-28153. PubMed ID: 28423653 [TBL] [Abstract][Full Text] [Related]
11. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma. Yan C; Niu Y; Li F; Zhao W; Ma L J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146 [TBL] [Abstract][Full Text] [Related]
12. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer. Yang KS; Xu CQ; Lv J Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive Molecular Analyses of an SLC Family-Based Model in Stomach Adenocarcinoma. Yu T; Yu SK; Lu KH Pathol Oncol Res; 2022; 28():1610610. PubMed ID: 36313898 [No Abstract] [Full Text] [Related]
14. Identification and Validation of an Individualized EMT-Related Prognostic Risk Score Formula in Gastric Adenocarcinoma Patients. Zhang D; Zhou S; Liu B Biomed Res Int; 2020; 2020():7082408. PubMed ID: 32309437 [TBL] [Abstract][Full Text] [Related]
15. Assessment of Clinicopathological Characteristics and Development of an Individualized Prognostic Model for Patients With Hepatoid Adenocarcinoma of the Stomach. Lin JX; Wang ZK; Hong QQ; Zhang P; Zhang ZZ; He L; Wang Q; Shang L; Wang LJ; Sun YF; Li ZX; Liu JJ; Ding FH; Lin ED; Fu YA; Lin SM; Xie JW; Li P; Zheng CH; Huang CM JAMA Netw Open; 2021 Oct; 4(10):e2128217. PubMed ID: 34609494 [TBL] [Abstract][Full Text] [Related]
16. Identification of a novel gene expression signature associated with overall survival in patients with lung adenocarcinoma: A comprehensive analysis based on TCGA and GEO databases. Zhao J; Guo C; Ma Z; Liu H; Yang C; Li S Lung Cancer; 2020 Nov; 149():90-96. PubMed ID: 33002836 [TBL] [Abstract][Full Text] [Related]
17. Early B-cell factors involve in the tumorigenesis and predict the overall survival of gastric cancer. Wang Q; Liang J; Hu X; Gu S; Xu Q; Yan J Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34100918 [TBL] [Abstract][Full Text] [Related]
18. Identification and Construction of a Long Noncoding RNA Prognostic Risk Model for Stomach Adenocarcinoma Patients. Zha Z; Zhang P; Li D; Liu G; Lu L Dis Markers; 2021; 2021():8895723. PubMed ID: 33680217 [TBL] [Abstract][Full Text] [Related]
19. Biomarker Identification through Multiomics Data Analysis of Prostate Cancer Prognostication Using a Deep Learning Model and Similarity Network Fusion. Wang TH; Lee CY; Lee TY; Huang HD; Hsu JB; Chang TH Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34064004 [TBL] [Abstract][Full Text] [Related]
20. A seven-gene prognostic model related to immune checkpoint PD-1 revealing overall survival in patients with lung adenocarcinoma. Niu W; Jiang L Math Biosci Eng; 2021 Jul; 18(5):6136-6154. PubMed ID: 34517527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]